LEXINGTON, Mass. and AMSTERDAM, the Netherlands, Aug. 30, 2018 (GLOBE NEWSWIRE) -- uniQure N.V. (NASDAQ: QURE), a leading gene therapy company advancing transformative therapies for patients with severe medical needs, today announced that it will participate in the following upcoming conferences in September:
• Wells Fargo Securities 2018 Healthcare Conference, September 5 – 6, 2018 at the Westin Copley Place in Boston, MA.
• Citi’s 13th Annual Biotech Conference, September 5 – 6, 2018 at the Four Seasons Hotel in Boston, MA.
• Goldman Sachs 8th Annual Biotech Symposium, September 7, 2018 at Goldman Sachs London Offices, in London, United Kingdom.
• 2018 Janney Healthcare Conference, September 17, 2018 at the Union League Club in New York City.
About uniQure
uniQure is delivering on the promise of gene therapy – single treatments with potentially curative results. We are leveraging our modular and validated technology platform to rapidly advance a pipeline of proprietary and partnered gene therapies to treat patients with liver/metabolic, central nervous system and cardiovascular diseases. www.uniQure.com
uniQure Contacts
For Investors: | For Media: | |||||
Maria E. Cantor | Eva M. Mulder | Tom Malone | ||||
Direct: 339-970-7536 | Direct: +31 20 240 6103 | Direct: 339-970-7558 | ||||
Mobile: 617-680-9452 | Mobile: +31 6 52 33 15 79 | Mobile: 339-223-8541 | ||||
[email protected] | [email protected] | [email protected] |